Maryland Cannabis Tax Revenue Hits $17.5M in Q1 2025
Adult-use program generates quarterly tax haul 18 months after launch, signaling sustained demand.

High angle view of the neoclassical ornate interior of the Texas State Capitol in Austin, Texas.
Revenue Run Rate and Year-Over-Year Growth
The Q1 2025 haul translates to a $70 million annual run rate, up from approximately $56 million collected in 2024. Maryland's adult-use program launched July 1, 2023, converting the state's existing medical framework into a dual-market structure. The Q1 figure represents a sequential uptick from Q4 2024's estimated $16.2 million, suggesting demand has stabilized after the initial post-launch surge.
Maryland levies a 9% excise tax on adult-use sales at the retail level, plus the standard 6% state sales tax. Medical cannabis remains exempt from the adult-use excise but still faces sales tax. The $17.5 million reflects excise collections only. Total tax receipts including sales tax run higher but aren't broken out in the preliminary report.
Key revenue metrics for Maryland's program:
- Q1 2025 excise tax: $17.5 million
- Implied Q1 retail sales (excise only): ~$194 million
- Annualized run rate (excise): $70 million
- 2024 full-year excise (estimated): $56 million
Competitive Context and Mid-Atlantic Comparisons
Maryland's $70 million annual excise run rate trails neighboring states with more mature programs but outpaces Delaware and Virginia, both of which have delayed adult-use rollouts. New Jersey collected approximately $126 million in cannabis excise tax in 2024. Pennsylvania—still medical-only—generated roughly $24 million in medical sales tax. Maryland's per-capita excise yield is tracking near $11 per resident annually, below the $15-20 range seen in established Western markets.
The state's 9% excise rate sits at the lower end of the national spectrum. Illinois charges 10-25% depending on THC content; California's combined state and local rates often exceed 25%. A lower tax burden has helped Maryland avoid the widespread illicit-market price arbitrage plaguing high-tax jurisdictions, though legacy operators remain active in Baltimore and the Eastern Shore.
For full background on this story, see the CannIntel topic hub on Maryland's adult-use program.
Allocation and Budget Impact
Maryland statute directs cannabis tax revenue into four buckets: public health, substance-abuse treatment, public schools, and a community-reinvestment fund targeting disproportionately impacted areas. The FY2026 state budget allocated $45 million in projected cannabis revenue across these categories, a figure the Q1 data suggests will be exceeded. The Cannabis Business Assistance Fund, capitalized at $10 million annually, provides grants and loans to social-equity applicants. Demand has outstripped funding in both application cycles to date.
Licensing remains a constraint on revenue growth. Maryland's Cannabis Administration has issued 103 adult-use retail licenses and 22 cultivation licenses as of May 2025, with a statutory cap of 150 retail and 30 cultivation permits statewide. The next application window opens in Q3 2025. It targets 25 additional retail slots reserved for social-equity applicants.
Frequently asked questions
How much cannabis tax revenue did Maryland collect in Q1 2025?
Maryland collected $17.5 million in adult-use cannabis excise tax during Q1 2025, according to state data released June 21. This translates to a $70 million annual run rate, up from approximately $56 million in full-year 2024.
What is Maryland's cannabis tax rate?
Maryland levies a 9% excise tax on adult-use cannabis sales at retail, plus the standard 6% state sales tax. Medical cannabis is exempt from the excise tax but subject to sales tax. The combined burden is lower than most legal states.
How does Maryland's cannabis tax revenue compare to other states?
Maryland's $70 million annualized excise run rate trails New Jersey (~$126M in 2024) but exceeds Pennsylvania's medical-only program (~$24M). Per-capita yield is approximately $11 per resident, below the $15-20 range in mature Western markets.
Where does Maryland's cannabis tax revenue go?
Revenue is allocated to public health, substance-abuse treatment, public schools, and a community-reinvestment fund for disproportionately impacted areas. The FY2026 budget allocated $45 million across these categories; Q1 data suggests that figure will be exceeded.
How many cannabis licenses has Maryland issued?
As of May 2025, Maryland has issued 103 adult-use retail licenses and 22 cultivation licenses. Statutory caps limit the state to 150 retail and 30 cultivation permits. The next application window opens in Q3 2025, targeting 25 social-equity retail slots.
Sources
The cannabis newsletter you forward to your team.
Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.
No spam. Unsubscribe with one click. 21+ only.
Related from Business

Nebraska cultivator cleared to plant first legal medical marijuana crop
State regulators issued the first cultivation license, marking the operational launch of Nebraska's voter-approved medical cannabis program.

FINO Cannabis Opens First Florida Dispensary in Market Expansion Push
The multistate operator launches its inaugural Florida retail location as competition intensifies in the state's medical cannabis market.

The Cannabis Business Advisors Launches DEA Compliance Platform
New software suite targets operators preparing for Schedule III registration requirements.
More from the newsroom

Virginia's $250 Public Marijuana Fine Draws Advocate Pushback
Reform groups challenge civil penalty structure as disproportionate to decriminalization intent under Va. Code § 4.1-600.

Marijuana Moment Petitions DEA Judge to Livestream Rescheduling Hearing
The news outlet filed a motion seeking public broadcast access to the administrative hearing on cannabis's Schedule III placement.

Minnesota Study Shows Medical Cannabis Improves Pain Patient Life Quality
State officials document significant gains in daily enjoyment among chronic pain patients enrolled in the medical program.